Hyperpigmentation, characterized by dark spots, post-acne marks, uneven skintone and age spots
is a common skin concern that affects many, impacting the overall appearance of the skin tone.
Melasyl, a groundbreaking ingredient developed by L'Oréal after 18 years of research and featured in La Roche-Posay's newest range MELA B3, has emerged as a potential solution targeting hyperpigmentation. This ingredient is designed to inhibit melanin synthesis, thereby
UV-induced skin darkening, crucial for maintaining an even skin tone.